Delivery Order SPE2DB25D3022-SPE2DB25FWBFE
- Not listed
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $12,604.63 for SKYRIZI 360 mg/2.4 ml on-body injectable pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of May 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was awarded on July 18, 2025. This award represents a non-set-aside, competitively awarded contract and constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of SKYRIZI 360 MG/2.4 ML on-body injectable medication. This firm fixed-price delivery order, valued at $11,830.00, was competitively awarded without set-aside provisions and is scheduled for completion by August 29, 2025. The contract represents a child order under...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. The award, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injection delivery systems. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 1, 2025. The contract represents a fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $35,490 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body auto-injector units. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of July 22, 2025, to be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectable medication, with a completion date of July 22, 2025. This is a firm fixed-price, non-set-aside contract awarded on June 30, 2025, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $23,660 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The company,...
- The Defense Logistics Agency has awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBFEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,604.63 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical pharmaceutical vendor within the DLA's global supply chain for military healthcare. SKYRIZI, a biologic medication used for treating inflammatory conditions, will be distributed from the company's Conshohocken facility to support Department of Defense healthcare operations. The non-set-aside competitive award demonstrates AmerisourceBergen's established capability to meet federal procurement requirements, consistent with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains through the DLA Troop Support Medical vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 4/23/25 |